#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

Případová studie pacienta

Direct Oral Anticoagulants and Their Reversal Agents –⁠ Current Options

19. 11. 2020 Source: Anticoagulant Treatment

In the last 10 years, the options for anticoagulant therapy have expanded with the introduction of direct oral anticoagulants (DOACs). It appears that DOACs may soon replace warfarin in the first line of prevention of venous thromboembolism, not only due to their clinical advantages but also thanks to newly available reversal agents that can be administered in case of major bleeding in patients taking DOACs. A recently published review article summarizes the current situation in this area.

PL_studie_doktor_ordinace

Two Is Not Enough: Efficacy of Alemtuzumab in Subsequent Cycles

The goal of the recent pooled analysis of the CARE-MS and TOPAZ study results published in the…
18. 11. 2020 Source: Multiple Sclerosis
jednotka_intenzivni_pece_jip

Different doses of LMWH in hospitalized patients with COVID-19 –⁠ interim experience

Many experts recommend administering heparin to patients with COVID-19 as part of anticoagulant…
18. 11. 2020 Source: Thromboprophylaxis

Depakine Chrono versus Other Valproates in the Treatment of Bipolar Disorder

Bipolar disorder is among the most severe psychiatric illnesses, and if not treated properly, it…
18. 11. 2020 Source: Bipolar Disorder
PL_dite_alergie_louka_kvetiny

Efficacy of Romiplostim in Children with Persistent or Chronic ITP

The effect of the thrombopoietin receptor agonist romiplostim in adult patients with immune…
18. 11. 2020 Source: Immune Thrombocytopenia
Výsledky

Experiences with AHA in Two Czech Centers and Risk Factor Evaluation

This summer, the journal Haemophilia published the results of an analysis of data from a relatively…
18. 11. 2020 Source: Hemophilia

Therapy of Chronic Leg Ulcers According to Evidence-Based Medicine

Chronic ulcers on the lower extremities are defined as trophic defects that show no signs of healing...
15. 11. 2020 Source: Wound Healing
zhodnocení výsledků vyšetření u lékaře 2356x1571

FLEX –⁠ A New Predictive Model for Assessing Follicular Lymphoma Risks

Overall survival of patients with advanced-stage follicular lymphoma (FL) who experience early…
14. 11. 2020 Source: Non-Hodgkin Lymphomas and CLL
Spolecnost_soudrznost_spolecne_drzici_se_ruce_sila_pratelstvi

Socio-economic Benefits of Using Obinutuzumab in 1st Line Treatment of Follicular Lymphoma

Pharmacoeconomic analyses remind us that our patients' diseases affect not only themselves or the…
14. 11. 2020 Source: Non-Hodgkin Lymphomas and CLL

Expression of PD-L1 in Patients with Advanced Non-Small Cell Lung Cancer

An international team of authors published a systematic review addressing the relationship between…
14. 11. 2020 Source: Immunotherapy in Oncology
1 129 130 131 132 133 169
Filter by speciality
Remove filters

Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#